HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

panvax

a pandemic influenza A/H1N1 vaccine

Networked: 3 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Vaccines: 124365
    - Viral Vaccines: 462
      - Influenza Vaccines: 6582
        panvax: 3

Experts

1.	Adhikari, Bishwa B: 1 article (01/2019)
2.	Carias, Cristina: 1 article (01/2019)
3.	Graitcer, Samuel B: 1 article (01/2019)
4.	Greening, Bradford: 1 article (01/2019)
5.	Kahn, Emily B: 1 article (01/2019)
6.	Lehnert, Jonathan D: 1 article (01/2019)
7.	Meltzer, Martin I: 1 article (01/2019)
8.	Au, Bijin: 1 article (01/2013)
9.	Bachmann, Martin F: 1 article (01/2013)
10.	Chye, De Hoe: 1 article (01/2013)

Related Diseases

1.

Human Influenza (Influenza)

01/01/2019 - "The PanVax Tool to Improve Pandemic Influenza Emergency Vaccination Program Readiness and Partnership."
01/01/2011 - "Panvax(®): a monovalent inactivated unadjuvanted vaccine against pandemic influenza A (H1N1) 2009."
01/01/2011 - "Panvax(®) (CSL Biotherapies, Parkville, Australia) is one of a number of pandemic influenza A (H1N1) 2009 (pH1N1) vaccines fast-tracked for production, clinical trials and licensure in response to the emergence of the novel pH1N1 strain in early-mid-2009. "
01/01/2013 - "When formulated with alum adjuvant and used to immunize mice, dose finding studies found that a 10 µg dose of this vaccine (3.7 µg globular HA content) induced antibody titers comparable to a 1.5 µg dose (0.7 µg globular HA content) of the licensed 2009 H1N1 pandemic vaccine Panvax, and significantly reduced viral titers in the lung following challenge with 2009 H1N1 pandemic influenza A/California/07/2009 virus. "

Related Drugs and Biologics

1.	Vaccines
2.	antineoplaston A10 (A 10)
3.	aluminum sulfate (alum)

Related Therapies and Procedures

1.	Biological Therapy